Cargando…
CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers
BACKGROUND: Centrosomal protein 55 (CEP55) plays a significant role in specific cancers. However, comprehensive research on CEP55 is lacking in pan-cancer. METHODS: In-house and multi-center samples (n = 15,823) were used to analyze CEP55 in 33 cancers. The variance of CEP55 expression levels among...
Autores principales: | Li, Guo-Sheng, Zhang, Wei, Huang, Wan-Ying, He, Rong-Quan, Huang, Zhi-Guang, Gan, Xiang-Yu, Yang, Zhen, Dang, Yi-Wu, Kong, Jin-Liang, Zhou, Hua-Fu, Chen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182662/ https://www.ncbi.nlm.nih.gov/pubmed/37173675 http://dx.doi.org/10.1186/s12890-023-02452-1 |
Ejemplares similares
-
CEP55 Positively Affects Tumorigenesis of Esophageal Squamous Cell Carcinoma and Is Correlated with Poor Prognosis
por: Yan, Shu-Mei, et al.
Publicado: (2021) -
The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC
por: Fu, Linhai, et al.
Publicado: (2020) -
CEP55 as a promising biomarker and therapeutic target on gallbladder cancer
por: Huang, Maotuan, et al.
Publicado: (2023) -
Data mining combined with experiments to validate CEP55 as a prognostic biomarker in colorectal cancer
por: Lin, Kang, et al.
Publicado: (2020) -
Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer
por: Xie, Xiaodong, et al.
Publicado: (2023)